Service: Stockholm3 - Diagnosing prostate cancer with OncoWatch

Responsible organisation: Karolinska Institutet in Sweden (Academic-Research)

EIT Health has played a key role in accelerating the development and implementation of Stockholm3 and the new AI system, OncoWatch through network and financial support. As part of the development of OncoWatch, the AI system will be validated in 2020 in a nine-country multicentre study to assess its performance across different labs and in a wider range of digital pathology scanners. A first CE-marked product is expected to launch by the end of the year.https://eithealth.eu/project/oncowatch/

Additional information

Source Open Innovation Regione Lombardia
Web site https://eithealth.eu/news-article/study-ai-system-effective-in-diagnosing-prostate-cancer/
Start/end date 2020 -
Still active?

Related cases